Skip to content

MetaVia Inc.

MTVA· NasdaqCore metricsCIK 1638287

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -10.62%
Market cap
$8.80M
6.74M shares
Filings
638
—
—
—
-$4.62M
Q3 2026N/M FY25 yoy
-$4.69M
Q3 2026N/M FY25 yoy
-$11.76M
Q3 2026derivedN/M FY25 yoy
-$0.69
Q3 2026N/M FY25 yoy
$8.78M
Q3 2026−35.8% FY25 yoy
$8.80M
—
—
3.6×
-178.45%
—

FY2025 figures · derived

Price

$1.3184.58%$7.16past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Net Interest Income

$510.00KFY 2025
$920.00K-$762.00K0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$510,000reported
FY 20242024-12-31$920,000reported
FY 20232023-12-31$461,000reported
FY 20212021-12-31$14,000reported
FY 20202020-12-31$39,000reported
FY 20192019-12-31$22,000reported
FY 20182018-12-31$40,000 revisedreported
FY 20172017-12-31$286,000reported
FY 20162016-12-31$114,000reported
FY 20152015-12-31$762,000reported
FY 20142014-12-31$55,000reported

Pharmaceutical preparations

MetaVia Inc. is the 423rd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

MetaVia Inc. · CIK 1638287 · Engraved from SEC EDGAR